31 results
8-K
EX-1.1
APLS
Apellis Pharmaceuticals Inc
1 Nov 23
Entry into a Material Definitive Agreement
7:59am
funding standards of Section 302 of the United States Employee Retirement Income Security Act of 1974, as amended (“ERISA”), and the regulations … -retirement benefit obligations” (within the meaning of Statement of Financial Accounting Standards 106) of the Company and its subsidiaries compared
8-K
EX-1.1
o0kb06zpg5 leidh
24 Mar 22
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8:18pm
8-K
EX-1.1
kv78w pyssq6b
20 Jan 22
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.1
ygnik2q67 lawjb
17 Nov 21
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
9:04am
8-K
EX-10.1
8qqwa8iir9z0vzt8
7 May 20
Apellis Pharmaceuticals Announces Private Placement of Convertible Senior Notes
7:44am
S-8
oagzxmf2 15bm4fjudf
27 Feb 20
Registration of securities for employees
12:00am
S-8
ofpgfi7 5jmby5
27 Feb 20
Registration of securities for employees
12:00am
8-K
EX-1.1
pfumf8f5nm
9 Jan 20
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5:22pm
S-3ASR
EX-4.3
n953 xikg4qi6qfr00fz
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
EX-4.4
7jn23rc
7 Jan 20
Automatic shelf registration
4:01pm
8-K
EX-10.1
es3dpx49
7 Oct 19
Departure of Directors or Certain Officers
4:06pm
POS AM
EX-1.2
mi1yp96up
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
8-K
EX-10.1
v2ya9
16 Sep 19
Apellis Pharmaceuticals Announces Closing of Offering of Convertible Senior Notes
5:17pm